Alpha Tau Medical (DRTSW) Assets Average (2022 - 2026)
Alpha Tau Medical (DRTSW) posted Assets Average of $107.2 million for Q1 2026, up 1.94% sequentially from $105.2 million in Q4 2025, and up 28.3% YoY from $83.6 million in Q1 2025.
Alpha Tau Medical (DRTSW) Assets Average (2022 - 2026) Analysis & Trends
Alpha Tau Medical has reported Assets Average for 5 years, with the latest figure at $107.2 million in Q1 2026.
- Quarterly Assets Average rose 28.3% year-over-year to $107.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107.2 million (up 28.3% YoY) and the FY2025 annual result came in at $95.9 million, down 0.9% from the prior year.
- Assets Average rose to $107.2 million in Q1 2026 per DRTSW's latest filing, from $105.2 million in the prior quarter.
- Over five years, Assets Average peaked at $121.7 million in Q3 2022 and troughed at $80.6 million in Q1 2022.
- A 5-year average of $104.5 million and a median of $106.9 million in 2023 frame the typical range for Assets Average.
- The sharpest annual moves came in 2023 and 2025: Assets Average surged 46.48% in 2023, then decreased 20.35% in 2025.
- Over 5 years, Assets Average stood at $119.8 million in 2022, then slipped by 10.75% to $106.9 million in 2023, then fell by 17.23% to $88.5 million in 2024, then advanced by 18.89% to $105.2 million in 2025, then increased by 1.94% to $107.2 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $107.2 million, $105.2 million, and $107.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Alpha Tau Medical | 383.00 Mn | 200.58 Mn | - | 121.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 121.51 Mn |
| Mar 31, 2026 | 107.21 Mn |
| Dec 31, 2025 | 105.17 Mn |
| Sep 30, 2025 | 107.82 Mn |
| Jun 30, 2025 | 95.94 Mn |
| Mar 31, 2025 | 83.57 Mn |
| Dec 31, 2024 | 88.47 Mn |
| Sep 30, 2024 | 93.39 Mn |
| Jun 30, 2024 | 99.25 Mn |
| Mar 31, 2024 | 104.92 Mn |
| Dec 31, 2023 | 106.88 Mn |
| Sep 30, 2023 | 108.79 Mn |
| Jun 30, 2023 | 113.63 Mn |
| Mar 31, 2023 | 118.10 Mn |
| Dec 31, 2022 | 119.76 Mn |
| Sep 30, 2022 | 121.67 Mn |
| Jun 30, 2022 | 121.51 Mn |
| Mar 31, 2022 | 80.63 Mn |